Stockreport

Comprehensive Insight on the Scleroderma Drug Pipeline Landscape Revealed in the Latest 2024 Report [Yahoo! Finance]

MITSUBISHI CH GRP U/ADR  (MTLHY) 
NASDAQ:AMEX Investor Relations: mitsubishichem-hd.co.jp/english/ir
PDF Current treatment regimens focus on symptom management and preventing the progression of the disease, but early diagnosis and intervention are crucial due to the progres [Read more]